Image Kyrapharm

A partnership for a complete offer

The Japanese group Fuji Silysia, created in 1931, is one of the global leaders in silica technology. Fuji Silysia produces and distributes a wide range of silica gels, micronized silica and products derived from silica (desiccants, dehumidifying compounds, absorbents, phases for chromatography) which cater to the needs of its clients or provide them with added value in markets as diverse as plastics, coatings, food, cosmetics and pharmaceutical products. Fuji Silysia has four plants in Japan as well as two research centres. The group also has 6 sales offices in Japan and around the world as well as two subsidiaries, one in the United States and another in Europe.

The Axyntis Group, an intermediate-sized company with estimated turnover of €100 M in 2014 and more than 420 employees, is a leading speciality chemicals company in France thanks to its GMP capabilities (700 m3). The group owns six sites (All’Chem in Montluçon, Centipharm in Grasse, Orgapharm in Pithiviers, Steiner in Saint Marcel and Synthexim in Calais, withtwo sites) and three R&D centres, all located in France. Its activities revolve around the life sciences (pharmacy, animal health, agrochemicals), dyes and speciality fine chemicals (electronics, photography, cosmetics, flavourings and perfumes, etc.)

Orgapharm, located in Pithiviers, is a subsidiary of the Axyntis Group. The site employs 95 people and has a total reactor volume of 90 m3. It has been inspected by the Food and Drug Administration (last inspection in 2014), the French National Agency for Drug and Health Product Safety (ANSM) and is also ISO 14001 certified. Main Axyntis Research & Development centre is located at Orgapharm, together with a GMP pilot plant as well as multipurpose synthesis plants and an automated GMP crystallisation/finishing unit. The entire production cycle is covered, from the laboratory to industrial production, thereby enabling support for a project in its entirety.